---
title: "Amneal wins FDA approval for additional iohexol injection strengths and vial sizes"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293033198.md"
description: "Amneal Pharmaceuticals received FDA approval for additional strengths and vial sizes of iohexol injection, expanding its generic OMNIPAQUE-referenced contrast portfolio. The launch is targeted for Q3 2026, aiming to meet broader US demand in hospitals and imaging centers. IQVIA estimates the US annual market for iohexol injections at approximately $706 million."
datetime: "2026-07-17T12:02:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293033198.md)
  - [en](https://longbridge.com/en/news/293033198.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293033198.md)
---

# Amneal wins FDA approval for additional iohexol injection strengths and vial sizes

-   Amneal won FDA clearance for new strengths and vial sizes of iohexol injection, expanding its generic OMNIPAQUE-referenced contrast portfolio. \* Launch targeted for Q3 2026; the company expects broader coverage of US demand across key hospital and imaging-center presentations. \* IQVIA estimates US annual iohexol injection sales at about $706 million for the 12 months ended May 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amneal Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607170800PRIMZONEFULLFEED9763692) on July 17, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [AMRX.US](https://longbridge.com/en/quote/AMRX.US.md)
- [IQV.US](https://longbridge.com/en/quote/IQV.US.md)

## Related News & Research

- [Amneal reprices term loan, cuts interest margin 50 bps on USD 2.08 billion facility](https://longbridge.com/en/news/294736497.md)
- [Dimensional Fund Advisors LP Raises Holdings in Amneal Pharmaceuticals, Inc. $AMRX](https://longbridge.com/en/news/294576137.md)
- [Richter, Adalvo expand tirzepatide co-development partnership for diabetes, obesity care](https://longbridge.com/en/news/295062917.md)
- [Novo Nordisk Ahead Of Plan To Deliver On $1.24 Billion Savings From Company Transformation, CFO Says](https://longbridge.com/en/news/294965872.md)
- [Evolus posts scientific investor presentation on Jeuveau, Evolysse HA fillers, Profhilo skin-quality injectable portfolio](https://longbridge.com/en/news/295023087.md)